Peptides
Learn
Tools
Providers
News
Find a provider
What is it?

Thymalin

Bovine thymus polypeptide complex

Not FDA-approved · no US pharmacy route
How it's delivered
  • Injection
  • Oral
  • Nasal spray
  • Suppository
  • Gel or cream

Injection — in short courses.

No provider we've verified carries Thymalin yet

Thymalin is a polypeptide complex extracted from the thymus glands of young calves. It’s not a single molecule — it’s a heterogeneous mixture of short peptides, ranging from two to eight amino acids, designed to support thymic function and T-cell production.

The thymus is where naive T-cells are trained. It sits behind the sternum and is responsible for teaching immune cells to distinguish self from non-self. The problem is that the thymus involutes with age — by 60, functional thymic tissue is a fraction of what it was at 20, and the body’s ability to generate new T-cell diversity drops accordingly. Thymalin’s proposed mechanism is to partially restore that function by stimulating hematopoietic stem cells toward T-lymphocyte maturation and modulating inflammatory cytokine signaling.

It has the longest clinical record of any thymic peptide and the thinnest Western recognition. That forty-year gap is the whole story.

The deep mechanistic story — including proposed epigenetic effects, specific dipeptide components like KE and EW, and the full Soviet-era research lineage — lives on our PeptideWellness deep-dive.

Last updated August 23, 2026 · PeptidesToGo Editorial Team · Educational, not medical advice

Thymalin structural signature
Is it for me?

Who it's for (or who should avoid)

What it's aimed at

Thymalin protocols have been used in Russian clinical medicine for:

  • Immune restoration after chemotherapy or radiation — rebuilding T-cell populations in patients with treatment-related immunosuppression
  • Chronic infections — supporting cellular immunity in those with recurrent or persistent infections
  • Age-related immune decline — addressing immunosenescence in older adults with measurable T-cell deficits
  • Post-viral recovery — studied in severe COVID-19 patients for lymphocyte recovery and cytokine modulation
  • Longevity-focused protocols — used in observational studies on healthspan and mortality in elderly cohorts

Every item on that list is Russian clinical practice, and all of it ran alongside immune monitoring — baseline and follow-up lymphocyte panels rather than a course taken on faith. None of it describes anything available in the United States.

Who should avoid it

  • Anyone in the United States or other jurisdictions where Thymalin is not legally available — the FDA has actively enforced against its sale
  • People with active autoimmune disease — immune modulation in this context requires specialist oversight
  • Anyone with a known allergy to bovine-derived proteins — Thymalin is an animal-source biological
  • Patients on immunosuppressive therapy — the interaction profile is not well-characterized
  • Anyone pregnant, breastfeeding, or planning pregnancy — no controlled human safety data

Thymalin is not a retail drug in the United States. It is a research-stage peptide here and an approved pharmaceutical elsewhere, and the two facts do not cancel out.

The current FDA enforcement posture makes lawful access in the United States unavailable. Readers considering thymic peptide therapy should discuss alternatives like Thymosin Alpha-1, which has a clearer regulatory path in some jurisdictions.

How would I take it?

Route, dose and course

Used forImmune restoration and age-related immune decline — in Russian clinical practice, not hereOur own summary
How it’s takenNot published5–10 mg injected daily for 5–10 days in the Russian protocols, in repeated courses rather than continuously. There is no lawful US route: not approved, on no 503A category list, not on the 503B Bulks List, and the FDA sent a distributor a warning letter in February 2024.See “How it’s administered”
What it isNot a molecule. A polypeptide complex extracted from the thymus glands of young calves, spanning roughly 1,000 to 10,000 daltons — a mixture of short peptides rather than one defined sequence.See “What it does”
Why the thymusThe thymus trains naive T-cells to tell self from non-self, and it shrinks with age: by 60 the functional tissue is a fraction of what it was at 20. The proposal is to partly restore that output.See “What it does”
What the evidence showsT-lymphocyte maturation from stem cells in vitro, recovery of T-cell subpopulations after immunosuppressive insult, and IL-6 modulation in severe COVID-19. The mortality finding in elderly cohorts is observational, not randomized.See the FAQ: “Is Thymalin FDA-approved?”
What it costsNot publishedNot applicable in the US, because there is no lawful US supply. Where it is an approved pharmaceutical it sits inside a national formulary rather than a retail price.See the FAQ: “How much does it cost?”

In Russian clinical protocols, Thymalin is typically administered as an intramuscular or subcutaneous injection. The peptide is supplied as a lyophilized powder and reconstituted with sterile saline immediately before use.

Protocols clinicians have historically used:

  • Standard course: 5–10 mg daily, intramuscular or subcutaneous, for 5–10 consecutive days
  • Cycling: courses are repeated at intervals (monthly, quarterly, or annually) rather than administered continuously
  • Immune monitoring: baseline and follow-up lymphocyte panels, CD4/CD8 ratios, and cytokine markers guide dosing
  • Stacking: sometimes combined with Epitalon (the pineal peptide from the same research program) in longevity-focused protocols

Because Thymalin is not legally available in the United States, these protocols reflect historical Russian clinical use rather than current US clinical practice. Nobody in this country is authorized to prepare it, so a protocol is a description of what has been done elsewhere, not an instruction.

The Russian program also produced Epitalon, the pineal peptide, and the two are sometimes combined in longevity protocols. That pairing is a research lineage rather than a demonstrated synergy, and it inherits every regulatory problem on this page.

What happens, and when?

The usual arc

Read this first. Individual response varies. Thymalin protocols are typically administered in courses rather than continuously, with immune markers monitored throughout.

There is no US course to expect anything from. What the research describes is a depleted immune system rebuilding rather than a healthy one being improved, measured on lymphocyte panels rather than on how anyone feels — and measured almost entirely by one research program, in one country, over four decades that produced no Western randomized trial.

  1. IN VITROWhere the mechanism was shownThymalin stimulates T-lymphocyte maturation from hematopoietic stem cells in cell culture. That is the cleanest result it has, and it is a dish rather than a person.
  2. AFTER AN INSULTWhere the clinical claim sitsThe recovery data is about T-cell subpopulations returning after immunosuppression — chemotherapy, radiation, severe infection — alongside IL-6 modulation reported in severe COVID-19 patients. A depleted immune system rebuilding is a narrower claim than immune enhancement.
  3. OVER YEARSThe observational findingKhavinson's 2002 elderly-cohort work reported reduced mortality. It is observational, from one research program, over a period no Western randomized trial has replicated — which is the whole gap between a forty-year record and a regulatory approval.
Can I actually get it?

No provider we've verified carries Thymalin yet

That is the honest answer, and it is not the same as "you can't have it". None of the licensed telehealth providers we track publishes Thymalin, so there is no price to quote and no intake to send you to. Whether that changes depends on federal action rather than on us — which is why the next box exists rather than a button that goes nowhere.

Tell me when someone carries it

One email, when a provider we've verified starts carrying Thymalin. Your state helps us tell you whether it will reach you.

What else do people ask?

Questions we get about Thymalin

Is Thymalin FDA-approved?

No — Thymalin is not FDA-approved and is not legally available in the United States. In February 2024, the FDA issued a warning letter to a U.S. distributor for selling it as an unapproved new drug. It has been approved for clinical use in Russia since the 1980s, but it does not appear on the FDA's 503A compounding list and cannot be lawfully prescribed or compounded in the U.S. under current regulations.

Is it legal?

In the United States, no — Thymalin is considered an unapproved new drug and its sale is actively enforced against by the FDA. In Russia and some other jurisdictions, it is a legally approved pharmaceutical. Because regulatory status varies significantly by country and is subject to enforcement action, confirm current legal availability in your jurisdiction before pursuing any protocol. A state-by-state check will not help here, because nothing about this one turns on state law: the barrier is federal.

Are there side effects?

The Russian clinical literature describes Thymalin as well-tolerated, with no significant adverse effects reported in long-term observational studies. However, as a bovine-derived polypeptide mixture, theoretical risks include immunogenic reactions and allergic responses. FDA adverse event reports include signals for chronic kidney disease and drug ineffectiveness, though causality has not been established. Western regulatory-standard safety data from large randomized trials does not exist.

Can I take it with my current medications?

Interaction data is limited. Because Thymalin modulates immune function and cytokine signaling, discuss any immunosuppressive medications, biologics, or chronic disease treatments with your provider before starting. The peptide has been used alongside standard therapies in Russian clinical settings, but formal drug-interaction studies are not available.

How much does it cost?

Because Thymalin is not legally available in the United States and sourcing outside approved pharmaceutical systems carries significant quality and legal risks, cost information is not applicable to U.S. patients. In jurisdictions where it is approved, pricing varies by healthcare system and is typically covered under national formularies rather than sold at retail.

We publish no medical reviewer by design. Every claim on this page traces to a source we hold on file, and the reviewed write-up with those citations lives on our hub. Read the full research on PeptideWellness ↗